Seeking Alpha

Medarex Inc. (MEDX)

()

News & PR
Market Currents

Buzz
Twitter: MEDX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Biotech: Q3 Market Update

Oct 16 • R. Scott Raynovich • 1 Comment
Three Recent Biotech Activist Wins by Carl Icahn

Aug 31 • Michael Becker • 4 Comments
81 Stocks Returning 35%+ in the Past Four Weeks

Aug 17 • TraderMark • 6 Comments
A Trend System for Stocks and ETFs

Aug 14 • Scott's Investments • 4 Comments
Too Late to Board the Biotech Bandwagon?

Jul 28 • Sam Subramanian • 5 Comments
VC Financings Boost Interest in Biotech

Jul 24 • The Burrill Report • Comment!
Healthcare Companies Report Growth, Surge of M&A Deals

Jul 24 • James Rickman • Comment!
Healthcare Industry: Innovation Is Necessary, But Not Cheap

Jul 24 • Andrew Corn • 1 Comment
Closing Update for Thursday, July 23: The Nasdaq Rally Lives On

Jul 23 • Midnight Trader • 3 Comments
Wall Street Breakfast: Must-Know News

Jul 23 • SA Editor Rachael Granby • 18 Comments
Preview from Europe: Nasdaq Continues Winning Streak, But Dow Disappoints

Jul 23 • The Mole • 2 Comments
Shares of HGSI Up Big in Anticipation of Clinical Trials Update

Jul 16 • M. E. Garza • 1 Comment
Wednesday's Options Recap

Jul 1 • Frederic Ruffy • 1 Comment
Our Monthly Buy / Sell List

Jun 29 • Value Expectations • Comment!
Much Ado About Medarex

Jun 25 • Michael Becker • 11 Comments
Is Medarex's Prostate Cancer Drug a Success? Too Early to Tell

Jun 23 • Derek Lowe • 8 Comments
Medarex's Vaccine-Like Prostate Cancer Treatment Shows Great Promise

Jun 23 • Prohost Biotech • Comment!
Medarex's 'Holy Grail' Against Prostate Cancer Causes Surge in Share Price

Jun 23 • M. E. Garza • 1 Comment
FDA Calendar Updates: Amgen, Amicus, Oncothyreon and Medarex

Jun 23 • Mike Havrilla • 1 Comment
Monday's Options Recap

Jun 22 • Frederic Ruffy • Comment!
On Palm, Medarex, Walgreen and Oracle

Jun 22 • optionMONSTER • 1 Comment
FDA, Clinical Trial Updates: JNJ, INCY, MEDX, CYTX, AGN, PPHM

May 29 • Mike Havrilla • 3 Comments
FDA, Clinical Trial Updates: Pro-Pharma Looks Promising

Apr 26 • Mike Havrilla • 5 Comments
Bright Prospects for Micromet (Part 2)

Apr 24 • Ohad Hammer • 3 Comments
Pre-Market Report: Stocks on Course for Lower Start

Apr 22 • Midnight Trader • 1 Comment
Updated FDA, Clinical Trial Calendars: Dendreon Releases Results

Apr 15 • Mike Havrilla • Comment!
Pequot Capital: Yet Another Hedge Fund Buying Gold

Mar 27 • Market Folly • 2 Comments
3 Top and Bottom Market Sectors for This Week

Dec 30, 2008 • J Clinton Hill • 2 Comments
Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008

Dec 24, 2008 • Market Folly • 3 Comments
FDA Calendar Update: High Hopes for Amgen's Bone Drug

Dec 21, 2008 • Mike Havrilla • Comment!
Three-Month, Updated FDA Decision Calendar

Dec 1, 2008 • Mike Havrilla • Comment!
Ustekinumab PDUFA Could Kick Start Medarex Revival

Nov 28, 2008 • EP Vantage • 1 Comment
FDA's "Risky Business" for Pharma & Biotech

Apr 29, 2008 • Mike Huckman • Comment!
What's Next For Medarex?

Dec 12, 2007 • Christopher Ssembonge • Comment!
Medarex Plunges On Disappointing Ipilimumab Trial

Dec 11, 2007 • SA Editor Judith Levy • Comment!
Thursday's Options Report: Morgan, Merrill, JP Morgan, Citigroup, Medarex, Raytheon, Manpower, AstraZeneca, Jos Bank Clothiers

Aug 9, 2007 • Andrew Wilkinson • Comment!
The "Naked" Truth About Antibodies For Cancer Therapy

Jul 5, 2007 • Ohad Hammer • 3 Comments
Cancer Stocks Slide Again

Jun 18, 2007 • Alan Brochstein • 1 Comment
Cancer Stocks Plunge Following ASCO Meeting

Jun 11, 2007 • Alan Brochstein • 3 Comments
Cancer Stocks Soar With Annual ASCO Meeting

Jun 4, 2007 • Alan Brochstein • 1 Comment
Cancer Stocks on the Go: Winners and Losers

May 29, 2007 • Alan Brochstein • 3 Comments

Medarex Inc. (MEDX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers